Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

Toward an Alzheimer's disease diagnosis via high-resolution blood gene expression.

Fehlbaum-Beurdeley P, Jarrige-Le Prado AC, Pallares D, Carrière J, Guihal C, Soucaille C, Rouet F, Drouin D, Sol O, Jordan H, Wu D, Lei L, Einstein R, Schweighoffer F, Bracco L.

Alzheimers Dement. 2010 Jan;6(1):25-38. doi: 10.1016/j.jalz.2009.07.001.

PMID:
20129318
2.

A gene expression pattern in blood for the early detection of Alzheimer's disease.

Booij BB, Lindahl T, Wetterberg P, Skaane NV, Sæbø S, Feten G, Rye PD, Kristiansen LI, Hagen N, Jensen M, Bårdsen K, Winblad B, Sharma P, Lönneborg A.

J Alzheimers Dis. 2011;23(1):109-19. doi: 10.3233/JAD-2010-101518.

PMID:
20930264
3.

Drug treatment of Alzheimer's disease patients leads to expression changes in peripheral blood cells.

Calciano MA, Zhou W, Snyder PJ, Einstein R.

Alzheimers Dement. 2010 Sep;6(5):386-93. doi: 10.1016/j.jalz.2009.12.004. Epub 2010 Feb 25.

PMID:
20185375
4.

Validation of AclarusDx™, a blood-based transcriptomic signature for the diagnosis of Alzheimer's disease.

Fehlbaum-Beurdeley P, Sol O, Désiré L, Touchon J, Dantoine T, Vercelletto M, Gabelle A, Jarrige AC, Haddad R, Lemarié JC, Zhou W, Hampel H, Einstein R, Vellas B; EHTAD/002 study group.

J Alzheimers Dis. 2012;32(1):169-81.

PMID:
22785402
5.

Increased plasma levels of soluble CD40, together with the decrease of TGF beta 1, as possible differential markers of Alzheimer disease.

Mocali A, Cedrola S, Della Malva N, Bontempelli M, Mitidieri VA, Bavazzano A, Comolli R, Paoletti F, La Porta CA.

Exp Gerontol. 2004 Oct;39(10):1555-61.

PMID:
15501026
6.

Single molecule profiling of tau gene expression in Alzheimer's disease.

Conrad C, Zhu J, Conrad C, Schoenfeld D, Fang Z, Ingelsson M, Stamm S, Church G, Hyman BT.

J Neurochem. 2007 Nov;103(3):1228-36. Epub 2007 Aug 28.

8.

Genomics and phenotypic profiles in dementia: implications for pharmacological treatment.

Cacabelos R, Fernández-Novoa L, Corzo L, Pichel V, Lombardi V, Kubota Y.

Methods Find Exp Clin Pharmacol. 2004 Jul-Aug;26(6):421-44.

PMID:
15349138
9.

Near-infrared spectroscopy of blood plasma for diagnosis of sporadic Alzheimer's disease.

Burns DH, Rosendahl S, Bandilla D, Maes OC, Chertkow HM, Schipper HM.

J Alzheimers Dis. 2009;17(2):391-7. doi: 10.3233/JAD-2009-1053.

PMID:
19363272
10.
11.

Interleukin-18 and transforming growth factor-beta 1 plasma levels in Alzheimer's disease and vascular dementia.

Malaguarnera L, Motta M, Di Rosa M, Anzaldi M, Malaguarnera M.

Neuropathology. 2006 Aug;26(4):307-12.

PMID:
16961066
12.

[Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].

Robert PH, Schuck S, Dubois B, Lépine JP, Gallarda T, Olié JP, Goni S, Troy S.

Encephale. 2003 May-Jun;29(3 Pt 1):266-72. French.

PMID:
12876552
13.

Use of serum insulin-like growth factor-I levels to predict psychiatric non-response to donepezil in patients with Alzheimer's disease.

Tei E, Yamamoto H, Watanabe T, Miyazaki A, Nakadate T, Kato N, Mimura M.

Growth Horm IGF Res. 2008 Feb;18(1):47-54. Epub 2007 Aug 21.

PMID:
17714966
14.

Chitotriosidase and inflammatory mediator levels in Alzheimer's disease and cerebrovascular dementia.

Di Rosa M, Dell'Ombra N, Zambito AM, Malaguarnera M, Nicoletti F, Malaguarnera L.

Eur J Neurosci. 2006 May;23(10):2648-56.

PMID:
16817867
15.

Genetics of Alzheimer's disease. A rapidly evolving field.

Serretti A, Olgiati P, De Ronchi D.

J Alzheimers Dis. 2007 Aug;12(1):73-92. Review.

PMID:
17851196
16.

Gene expression profile analysis of lymphocytes from Alzheimer's patients.

Kálmán J, Kitajka K, Pákáski M, Zvara A, Juhász A, Vincze G, Janka Z, Puskás LG.

Psychiatr Genet. 2005 Mar;15(1):1-6.

PMID:
15722950
17.

Ectopic expression of phospho-Smad2 in Alzheimer's disease: uncoupling of the transforming growth factor-beta pathway?

Lee HG, Ueda M, Zhu X, Perry G, Smith MA.

J Neurosci Res. 2006 Dec;84(8):1856-61.

PMID:
16998902
18.

The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristics.

Jones RW, Kivipelto M, Feldman H, Sparks L, Doody R, Waters DD, Hey-Hadavi J, Breazna A, Schindler RJ, Ramos H; LEADe investigators.

Alzheimers Dement. 2008 Mar;4(2):145-53. doi: 10.1016/j.jalz.2008.02.001.

PMID:
18631958
19.

Rationale and study design of the CardioGene Study: genomics of in-stent restenosis.

Ganesh SK, Skelding KA, Mehta L, O'Neill K, Joo J, Zheng G, Goldstein J, Simari R, Billings E, Geller NL, Holmes D, O'Neill WW, Nabel EG.

Pharmacogenomics. 2004 Oct;5(7):952-1004.

PMID:
15469413
20.

Gene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysis.

Luo J, Dunn T, Ewing C, Sauvageot J, Chen Y, Trent J, Isaacs W.

Prostate. 2002 May 15;51(3):189-200.

PMID:
11967953

Supplemental Content

Support Center